We serve Chemical Name:Solvent Blue 97 CAS:32724-62-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Solvent Blue 97
CAS.NO:32724-62-2
Synonyms:abcol blue rr;Macrolex Blue RR.;Keyplast Blue E
Molecular Formula:C36H38N2O2
Molecular Weight:530.69900
HS Code:2922399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:641.1ºC at 760 mmHg
Density:1.166g/cm3
Index of Refraction:1.646
PSA:58.20000
Exact Mass:530.29300
LogP:8.96160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like abcol blue rr chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Keyplast Blue E physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,abcol blue rr Use and application,Macrolex Blue RR. technical grade,usp/ep/jp grade.
Related News: An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. Solvent Blue 97 manufacturer Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization. Solvent Blue 97 supplier ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses. Solvent Blue 97 vendor An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. Solvent Blue 97 factory Alira is betting big on biometrics services by picking up Italy-based CROS NT, which has offices in Italy, London and North Carolina. The deal, for undisclosed terms, gives a boost to Alira’s direct clinical operations in Europe and access to biometrics services from the 29-year-old contract research organization.
